SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-24-001356
Filing Date
2024-03-11
Accepted
2024-03-11 13:14:39
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 bdtx13gafeb24.txt SC 13G/A 4965
  Complete submission text file 0001897612-24-001356.txt   6636
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Subject) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91312
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

IRS No.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G/A